Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05759910 · ClinicalTrials.gov registry record · NA
Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals
A NA study, sponsored by Microphyt.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05759910: Completed NA study, sponsored by Microphyt.
NCT05759910 is a NA study that has completed, run by Microphyt. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05759910, a NA study, has completed, sponsored by Microphyt.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if BrainPhyt, a microalgae based ingredient may affect cognitive function parameters in older healthy individuals with evidence of age-related cognitive decline. In a double blind, randomized manner, 40 free living males and females between 55 to 75 years with age-associated memory decline will ingest Brainphyt supplement or Placebo for 12 weeks. Cognitive function battery will be realized after 4 and 12 weeks of supplementation.
Primary Outcome
Mean Span Score in Corsi Blocks module of the COMPASS
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Brainphyt high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT05759910 record still lists
NCT05759910 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05759910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05759910 about?
NCT05759910 is a clinical study titled "Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals". The purpose of this study is to evaluate if BrainPhyt, a microalgae based ingredient may affect cognitive function parameters in older healthy individuals with evidence of age-related cognitive decline. In a double blind, randomized manner, 40 free living males and females between 55 to 75 years wi...
What is the current status of trial NCT05759910?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-05-01. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT05759910?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Brainphyt high dose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05759910?
This trial is sponsored by Microphyt, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05759910's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI